| __timestamp | Alkermes plc | Arrowhead Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7753000 | 23138050 |
| Thursday, January 1, 2015 | 4019000 | 57410147 |
| Friday, January 1, 2016 | 2301000 | 41454452 |
| Sunday, January 1, 2017 | 7232000 | 31690298 |
| Monday, January 1, 2018 | 68895000 | 52968505 |
| Tuesday, January 1, 2019 | 52816000 | 81048686 |
| Wednesday, January 1, 2020 | 1946000 | 128874979 |
| Friday, January 1, 2021 | 1020000 | 206342000 |
| Saturday, January 1, 2022 | 393842000 | 297307000 |
| Sunday, January 1, 2023 | 270806000 | 353188000 |
| Monday, January 1, 2024 | 245326000 | 505870000 |
Unleashing the power of data
In the ever-evolving landscape of biopharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Alkermes plc and Arrowhead Pharmaceuticals, Inc. have been at the forefront of this transformative journey. From 2014 to 2023, Arrowhead Pharmaceuticals has consistently increased its R&D budget, culminating in a remarkable 1,500% growth by 2023. In contrast, Alkermes plc experienced a more volatile trajectory, with a significant spike in 2022, where their R&D expenses surged by over 5,000% compared to 2014. This fluctuation highlights the dynamic nature of R&D investments in response to market demands and scientific breakthroughs. As we look to the future, the missing data for Alkermes in 2024 leaves us anticipating their next strategic move. These trends underscore the critical role of R&D in driving the next wave of medical advancements.
Johnson & Johnson or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Insights: How Merck & Co., Inc. and Arrowhead Pharmaceuticals, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Alkermes plc
R&D Spending Showdown: Incyte Corporation vs Arrowhead Pharmaceuticals, Inc.
Research and Development Investment: Pharming Group N.V. vs Alkermes plc
Research and Development Investment: Corcept Therapeutics Incorporated vs Alkermes plc
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Arrowhead Pharmaceuticals, Inc. Allocate Funds
R&D Insights: How Arrowhead Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. Allocate Funds
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Geron Corporation
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.